PE34998A1 - Un atomizador nasal que contiene un esteroide intranasal y un antihistaminico - Google Patents
Un atomizador nasal que contiene un esteroide intranasal y un antihistaminicoInfo
- Publication number
- PE34998A1 PE34998A1 PE00092996A PE00092996A PE34998A1 PE 34998 A1 PE34998 A1 PE 34998A1 PE 00092996 A PE00092996 A PE 00092996A PE 00092996 A PE00092996 A PE 00092996A PE 34998 A1 PE34998 A1 PE 34998A1
- Authority
- PE
- Peru
- Prior art keywords
- antihistamine
- anticolynergic
- mixtures
- atomizer containing
- nasal atomizer
- Prior art date
Links
- 230000001387 anti-histamine Effects 0.000 title abstract 2
- 239000000739 antihistaminic agent Substances 0.000 title abstract 2
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 title 1
- 150000003431 steroids Chemical class 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 3
- MBUVEWMHONZEQD-UHFFFAOYSA-N Azeptin Chemical compound C1CN(C)CCCC1N1C(=O)C2=CC=CC=C2C(CC=2C=CC(Cl)=CC=2)=N1 MBUVEWMHONZEQD-UHFFFAOYSA-N 0.000 abstract 1
- KUVIULQEHSCUHY-XYWKZLDCSA-N Beclometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O KUVIULQEHSCUHY-XYWKZLDCSA-N 0.000 abstract 1
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 abstract 1
- ZKLPARSLTMPFCP-UHFFFAOYSA-N Cetirizine Chemical compound C1CN(CCOCC(=O)O)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-UHFFFAOYSA-N 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 230000003042 antagnostic effect Effects 0.000 abstract 1
- 229960004574 azelastine Drugs 0.000 abstract 1
- 229960004495 beclometasone Drugs 0.000 abstract 1
- 229960004436 budesonide Drugs 0.000 abstract 1
- 229960001803 cetirizine Drugs 0.000 abstract 1
- 229960000676 flunisolide Drugs 0.000 abstract 1
- 229960002714 fluticasone Drugs 0.000 abstract 1
- MGNNYOODZCAHBA-GQKYHHCASA-N fluticasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(O)[C@@]2(C)C[C@@H]1O MGNNYOODZCAHBA-GQKYHHCASA-N 0.000 abstract 1
- 239000003862 glucocorticoid Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 229960003088 loratadine Drugs 0.000 abstract 1
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 abstract 1
- 229960001664 mometasone Drugs 0.000 abstract 1
- QLIIKPVHVRXHRI-CXSFZGCWSA-N mometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CCl)(O)[C@@]1(C)C[C@@H]2O QLIIKPVHVRXHRI-CXSFZGCWSA-N 0.000 abstract 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 abstract 1
- MIXMJCQRHVAJIO-TZHJZOAOSA-N qk4dys664x Chemical compound O.C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O.C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O MIXMJCQRHVAJIO-TZHJZOAOSA-N 0.000 abstract 1
- 230000001932 seasonal effect Effects 0.000 abstract 1
- 229960005294 triamcinolone Drugs 0.000 abstract 1
- GFNANZIMVAIWHM-OBYCQNJPSA-N triamcinolone Chemical compound O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 GFNANZIMVAIWHM-OBYCQNJPSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
SE REFIERE A UNA COMPOSICION, QUE COMPRENDE: a) UN GLUCOCORTICOIDE SELECCIONADO DE BECLOMETASONA, FLUNISOLIDA, TRIAMCINOLONA, FLUTICASONA, MOMETASONA, BUDESONIDA O MEZCLAS DE ESTOS; b) UN ANTIHISTAMINICO INHIBIDOR DE LEUCOTRIENO SELECCIONADO DE CETIRIZINA, LORATADINA, AZELASTINA O MEZCLAS DE ESTOS; c) UN VEHICULO INTRANASAL Y, OPCIONALMENTE, PUEDE CONTENER UNA AMINA SIMPATICOMIMETICA, UN AGENTE ANTIINFLAMATORIO NO ESTEROIDEO, UN INHIBIDOR O ANTAGONISTA DE LIPOXIGENASA, UN ANALGESICO NO OPIATO, UN ANTICOLINERGICO, UN MUCOLITICO O UN ANTIALERGICO ENTRE OTROS. SIENDO UTIL EN EL TRATAMIENTO DE LOS SINTOMAS DE RINOCONJUNTIVITIS ESTACIONAL O CONTINUA
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57479195A | 1995-12-19 | 1995-12-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE34998A1 true PE34998A1 (es) | 1998-07-24 |
Family
ID=24297657
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE00092996A PE34998A1 (es) | 1995-12-19 | 1996-12-18 | Un atomizador nasal que contiene un esteroide intranasal y un antihistaminico |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0780127A1 (es) |
| AR (1) | AR005138A1 (es) |
| CO (1) | CO4780018A1 (es) |
| PE (1) | PE34998A1 (es) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5849263A (en) * | 1993-03-30 | 1998-12-15 | Charlotte-Mecklenburg Hospital Authority | Pharmaceutical compositions containing alkylaryl polyether alcohol polymer |
| US7211582B1 (en) | 1994-12-30 | 2007-05-01 | Sepracor Inc. | Methods for treating urticaria using descarboethoxyloratadine |
| US7214683B1 (en) | 1994-12-30 | 2007-05-08 | Sepracor Inc. | Compositions of descarboethoxyloratadine |
| JPH11511758A (ja) * | 1996-06-04 | 1999-10-12 | ザ、プロクター、エンド、ギャンブル、カンパニー | 鼻腔用ステロイドと抗ヒスタミン剤を含む鼻腔内噴霧薬 |
| US5976573A (en) * | 1996-07-03 | 1999-11-02 | Rorer Pharmaceutical Products Inc. | Aqueous-based pharmaceutical composition |
| FR2756739B1 (fr) * | 1996-12-05 | 2000-04-28 | Astra Ab | Nouvelle formulation de budesonide |
| SE9604486D0 (sv) * | 1996-12-05 | 1996-12-05 | Astra Ab | Novel formulation |
| WO1998048839A1 (en) * | 1997-04-30 | 1998-11-05 | Warner-Lambert Company | Topical nasal antiinflammatory compositions |
| CN1283115A (zh) * | 1997-12-23 | 2001-02-07 | 先灵公司 | 用于治疗呼吸道和皮肤病的含有至少一种白三烯拮抗剂和至少一种抗组胺药的组合物 |
| GB9806937D0 (en) | 1998-03-31 | 1998-05-27 | Procter & Gamble | A spray device |
| AU2003204684B2 (en) * | 1998-04-14 | 2005-11-24 | Sepracor, Inc. | Methods and compositions using cetrizine in compostion with leukotriene inhibitors for treating conditions responsive to leukotriene inhibition |
| US6384038B1 (en) * | 1998-04-14 | 2002-05-07 | Sepracor Inc. | Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants |
| US6248308B1 (en) | 1998-04-14 | 2001-06-19 | Sepracor Inc. | Methods of using norastemizole in combination with leukotriene inhibitors to treat or prevent asthma |
| PA8481801A1 (es) * | 1998-09-10 | 2000-09-29 | Schering Corp | Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando antihistaminas |
| EP1020233A1 (en) | 1999-01-13 | 2000-07-19 | The Procter & Gamble Company | Dosing and delivering system |
| JP2001510485A (ja) * | 1999-03-01 | 2001-07-31 | シェーリング コーポレイション | アトピー性皮膚炎、血管性浮腫および他の障害を抗ヒスタミン薬およびグルココルチコイドを用いて処置するための組成物および方法 |
| GB9918559D0 (en) * | 1999-08-07 | 1999-10-06 | Glaxo Wellcome Kk | Novel pharmaceutical formulation |
| AU7859800A (en) * | 1999-10-08 | 2001-04-23 | Schering Corporation | Topical nasal treatment |
| DE10064950A1 (de) * | 2000-12-23 | 2002-07-11 | Impetus Ag Basel | Thixotropes Nasenspray |
| DK1446119T3 (da) | 2001-09-18 | 2006-07-10 | Nycomed Danmark Aps | Præparater omfattende Ipratropium og xylometazolin til behandling af almindelig forkölelse |
| GB2389530B (en) * | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
| ES2393864T3 (es) | 2002-08-30 | 2012-12-28 | Nycomed Gmbh | El uso de la asociación de ciclesonida y antihistaminas para el tratamiento de rinitis alérgica |
| NZ538859A (en) | 2002-09-20 | 2006-12-22 | Fmc Corp | Cosmetic sunscreen composition containing microcrystalline cellulose |
| WO2004082589A2 (en) * | 2003-03-20 | 2004-09-30 | Ranbaxy Laboratories Limited | Nasally administrable, bioavailable pharmaceutical composition of loratadine |
| TW200522932A (en) * | 2003-09-15 | 2005-07-16 | Combinatorx Inc | Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines |
| US20070020330A1 (en) * | 2004-11-24 | 2007-01-25 | Medpointe Healthcare Inc. | Compositions comprising azelastine and methods of use thereof |
| US8758816B2 (en) | 2004-11-24 | 2014-06-24 | Meda Pharmaceuticals Inc. | Compositions comprising azelastine and methods of use thereof |
| PL2522365T3 (pl) | 2004-11-24 | 2017-05-31 | Meda Pharmaceuticals Inc. | Kompozycje zawierające azelastynę i sposoby ich zastosowania |
| CA2602341A1 (en) | 2005-03-23 | 2006-09-28 | Elan Pharma International Limited | Nanoparticulate corticosteroid and antihistamine formulations |
| RU2308272C1 (ru) * | 2006-08-30 | 2007-10-20 | Общество с ограниченной ответственностью "ЮНАЛ" | Лекарственная композиция, обладающая антиаллергическим и противовоспалительным действием |
| WO2008070264A2 (en) * | 2006-10-10 | 2008-06-12 | Case Western Reserve University | Nasal spray composition and method for treating rhinitis, sinusitis or both |
| WO2011141929A2 (en) | 2010-05-11 | 2011-11-17 | Cadila Healthcare Limited | Aqueous pharmaceutical compositions of fluticasone and olopatadine |
| RU2543326C2 (ru) * | 2012-08-21 | 2015-02-27 | Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") | Фармацевтическая композиция для лечения зуда кожи |
| US9949989B2 (en) | 2014-04-16 | 2018-04-24 | John T. Given | Intranasal medication delivery device and method of use thereof |
| US11135155B2 (en) | 2014-07-08 | 2021-10-05 | Hikma Pharmaceuticals Usa Inc. | Liquid naloxone spray |
| CN107929738A (zh) * | 2017-11-28 | 2018-04-20 | 贵州云峰药业有限公司 | 一种含盐酸氮卓斯汀的组合物 |
| WO2022098319A1 (en) * | 2020-11-09 | 2022-05-12 | Pharmactive Ilac Sanayi Ve Ticarey A.S. | Pharmaceutical compositions comprising azelastine, beclomethasone and relevant excipients |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4136163A (en) | 1971-02-04 | 1979-01-23 | Wilkinson Sword Limited | P-menthane carboxamides having a physiological cooling effect |
| GB1421743A (en) | 1972-04-18 | 1976-01-21 | Wilkinson Sword Ltd | Ingestible topical and other compositions |
| ZA821577B (en) | 1981-04-06 | 1983-03-30 | Boots Co Plc | Therapeutic agents |
| JPS5888334A (ja) | 1981-11-20 | 1983-05-26 | Takasago Corp | ３−ｌ−メントキシプロパン−１、２−ジオ−ル |
| US4767612A (en) | 1987-01-23 | 1988-08-30 | Rorer Pharmaceutical Corporation | Triamcinolone acetonide for the treatment of allergic rhinitis |
| US4873259A (en) | 1987-06-10 | 1989-10-10 | Abbott Laboratories | Indole, benzofuran, benzothiophene containing lipoxygenase inhibiting compounds |
| EP0318093A3 (en) | 1987-11-25 | 1990-12-05 | Merck Frosst Canada Inc. | Diarylquinoline diacids and their use as medicaments |
| TW401300B (en) * | 1992-12-25 | 2000-08-11 | Senju Pharma Co | Antiallergic composition for ophthalmic or nasal use |
-
1996
- 1996-12-05 EP EP96308852A patent/EP0780127A1/en not_active Withdrawn
- 1996-12-13 CO CO96065607A patent/CO4780018A1/es unknown
- 1996-12-18 PE PE00092996A patent/PE34998A1/es not_active Application Discontinuation
- 1996-12-18 AR ARP960105765A patent/AR005138A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CO4780018A1 (es) | 1999-05-26 |
| EP0780127A1 (en) | 1997-06-25 |
| AR005138A1 (es) | 1999-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE34998A1 (es) | Un atomizador nasal que contiene un esteroide intranasal y un antihistaminico | |
| DK1719512T3 (da) | Sarsasapogenin og smilagenin til behandling af cognitive dysfunktioner | |
| AR025923A1 (es) | Nueva combinacion de loteprednol y antihistaminicos | |
| CY1109212T1 (el) | Φαρμακευτικες συνθεσεις για την θεραπεια του ασθμα | |
| IT1317904B1 (it) | Formulazione farmaceutica di propionato di fluticasone. | |
| CY1107512T1 (el) | Νεες υποκατεστημενες με βενζιμιδαζολιο μορφες δοσολογιας και μεθοδος για τη χρηση τους | |
| AR020999A1 (es) | Composiciones y proceso para la elaboracion de isotretinoina | |
| NO20013966D0 (no) | Kombinasjoner for behandling av sykdommer som involverer angiogenese | |
| HUP0000487A2 (hu) | Neurokinin antagonistaként alkalmazható szubsztituált oximszármazékok | |
| SE9703407D0 (sv) | New use | |
| TW200504078A (en) | Therapeutically active compounds and their use | |
| TR200301613T2 (tr) | Sapogenin türevleri, bunların sentezi ve kullanımı, bunların kullanım metotları. | |
| PT1037604E (pt) | Composicoes farmaceuticas de aerossol | |
| EE200100136A (et) | Atsetüülkoliini esteraasi inhibiitori ja psühhoosivastase toimeaine kasutamine ravimi valmistamiseks, mis on ette nähtud kognitsiooni- ja psühhoosihäirete raviks, ning neid aineid sisaldav farmatseutiline kompositsioon | |
| DK279790A (da) | Aromatiske steroid-5-alfa-reduktaseinhibitorer | |
| DK0712311T3 (da) | Antiglucocorticoidsteroider til behandling af angstlidelser | |
| DK1467762T3 (da) | Anvendelse af en H1-antagonist og rimexolon som et sikkert steroid til behandling af rhinitis | |
| NO20025394L (no) | Formuleringer inneholdende et glukokorticoid legemiddel for behandling av bronkopulmon¶re sykdommer | |
| DE60229411D1 (de) | Verfahren zur hemmung der verschlechterung der kognitiven leistungsfähigkeit bei erwachsenen mit down-syndrom | |
| MY138479A (en) | 7alpha-hydroxyacetyl and 7alpha-hydroperoxyacetyl-substituted steroid compounds | |
| SE0300445D0 (sv) | New combination | |
| MXPA05008347A (es) | Composicion que comprende una combinacion de un inhibidor de aromatasa, una progestina y un estrogeno y su uso para el tratamiento de endometriosis. | |
| ATE433457T1 (de) | Angiogen-wirkende trisulfat steroide und deren verwendung | |
| ES2126155T3 (es) | Nuevos compuestos aminoesteroidales que contienen uretano. | |
| ATE419855T1 (de) | Therapie für hormonersatz und depression enthaltend dienogest |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FX | Voluntary withdrawal |